<DOC>
	<DOCNO>NCT00559338</DOCNO>
	<brief_summary>The purpose study determine 8hr infusion nesiritide emergency department Acutely decompensated heart failure patient decrease 30 day recidivism .</brief_summary>
	<brief_title>Impact Nesiritide Infusion Decompensated Heart Failure Emergency Department</brief_title>
	<detailed_description>In view high return admission rate county ED heart failure , hypothesize high risk patient population might realize decrease return admission rate benefit early ED administration nesiritide . We also acknowledge safety nesiritide patient population well establish . Thus , opt test hypothesis 8-hour ED infusion nesiritide [ addition protocol specify standard therapy ] ADHF patient urban patient population consist predominately African Americans Hispanics decrease 30-day readmission rate without provoke harm .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>Patients adult great 18 year age A history establish heart failure Dyspnea rest minimal exertion respiratory rate great 24 breath per minute Evidence volume overload base physical exam finding chest radiograph , brain natriuretic peptide ( BNP ) level great 100 pg/ml . Systolic blood pressure le 90 mm Hg Frank impend cardiogenic shock Cardiopulmonary arrest Evidence low cardiac output ( cold clammy extremity Mental status change ) New onset congestive heart failure Suspected acute coronary syndrome ( elevated troponin , New electrocardiographic change , history consistent cardiac ischemia ) High clinical suspicion pulmonary embolism Endstage renal disease ( dialysis imminent ) Active use nitroglycerin inotropic infusion ED Ventricular tachycardia Allergy nesiritide component Patient need intravenously diuretic therapy ED Normal BNP level Inability followup Pregnancy suspect pregnancy ; Actively receive investigational drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>CHF</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Dyspnea</keyword>
	<keyword>Cardiomyopathy</keyword>
</DOC>